Anish Suri has more than 20 years of experience in immuno-oncology, autoimmune disorders, transplantation rejection, and inflammation. Prior to joining Cue Biopharma, he held roles of increasing responsibility at Janssen Pharmaceutical Companies, including a key leadership position overseeing strategic immunology initiatives. Prior to Janssen, he was responsible for providing strategic guidance to immuno-oncology and immunology programs at Bristol-Myers Squibb Pharmaceutical Research Institute. Previously, Dr. Suri was Assistant Professor of Pathology and Immunology at Washington University School of Medicine.
.svg)
